Healthcare provider profile · identity verified

Angela Dawn Pope-Bailey, ARNP

Nurse Practitioner · CLINTON, OK · NPI 1629209721

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	598	125
Atorvastatin Calcium	Atorvastatin Calcium	364	106
Gabapentin	Gabapentin	349	77
Lisinopril	Lisinopril	321	83
Potassium Chloride	Potassium Chloride	306	75
Omeprazole	Omeprazole	281	87
Pantoprazole Sodium	Pantoprazole Sodium	278	74
Amlodipine Besylate	Amlodipine Besylate	273	69
Prednisone	Prednisone	273	165
Sertraline Hcl	Sertraline Hcl	244	53
Furosemide	Furosemide	234	65
Meloxicam	Meloxicam	234	72
Metoprolol Succinate	Metoprolol Succinate	191	50
Rosuvastatin Calcium	Rosuvastatin Calcium	184	55
Hydrochlorothiazide	Hydrochlorothiazide	169	49
Metformin Hcl	Metformin Hcl	168	45
Montelukast Sodium	Montelukast Sodium	168	46
Losartan Potassium	Losartan Potassium	147	46
Allopurinol	Allopurinol	142	36
Trazodone Hcl	Trazodone Hcl	140	31
Clopidogrel	Clopidogrel Bisulfate	138	39
Ozempic	Semaglutide	137	30
Albuterol Sulfate Hfa	Albuterol Sulfate	132	69
Simvastatin	Simvastatin	131	35
Donepezil Hcl	Donepezil Hcl	126	23
Eliquis	Apixaban	126	29
Glipizide	Glipizide	125	29
Fluticasone Propionate	Fluticasone Propionate	122	43
Pregabalin	Pregabalin	118	22
Tamsulosin Hcl	Tamsulosin Hcl	113	29
Carvedilol	Carvedilol	112	31
Ibuprofen	Ibuprofen	111	41
Alendronate Sodium	Alendronate Sodium	105	32
Buspirone Hcl	Buspirone Hcl	98	27
Tramadol Hcl	Tramadol Hcl	96	26
Farxiga	Dapagliflozin Propanediol	85	21
Famotidine	Famotidine	84	25
Ventolin Hfa	Albuterol Sulfate	80	20
Metoprolol Tartrate	Metoprolol Tartrate	76	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	76	12
Venlafaxine Hcl Er	Venlafaxine Hcl	76	12
Estradiol	Estradiol	74	21
Olmesartan Medoxomil	Olmesartan Medoxomil	74	15
Bupropion Xl	Bupropion Hcl	72	14
Ondansetron Hcl	Ondansetron Hcl	71	33
Alprazolam	Alprazolam	68	19
Bydureon Bcise	Exenatide Microspheres	66	suppressed
Pravastatin Sodium	Pravastatin Sodium	66	22
Escitalopram Oxalate	Escitalopram Oxalate	64	20
Januvia	Sitagliptin Phosphate	64	suppressed
Azithromycin	Azithromycin	62	55
Fluoxetine Hcl	Fluoxetine Hcl	62	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	61	12
Levofloxacin	Levofloxacin	61	55
Acetaminophen-Codeine	Acetaminophen With Codeine	60	22
Oxybutynin Chloride Er	Oxybutynin Chloride	59	14
Duloxetine Hcl	Duloxetine Hcl	58	12
Tizanidine Hcl	Tizanidine Hcl	57	23
Amitriptyline Hcl	Amitriptyline Hcl	56	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	17
Ropinirole Hcl	Ropinirole Hcl	54	13
Zolpidem Tartrate	Zolpidem Tartrate	54	15
Cephalexin	Cephalexin	53	29
Valsartan	Valsartan	53	17
Jardiance	Empagliflozin	52	11
Celecoxib	Celecoxib	50	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	49	36
Amoxicillin	Amoxicillin	48	43
Liothyronine Sodium	Liothyronine Sodium	47	suppressed
Lorazepam	Lorazepam	47	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	46	suppressed
Fluconazole	Fluconazole	45	27
Sucralfate	Sucralfate	45	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	20
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	44	37
Diclofenac Sodium	Diclofenac Sodium	43	12
Ezetimibe	Ezetimibe	43	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	42	36
Spironolactone	Spironolactone	42	14
Citalopram Hbr	Citalopram Hydrobromide	41	14
Gemfibrozil	Gemfibrozil	41	suppressed
Breo Ellipta	Fluticasone/Vilanterol	40	suppressed
Paroxetine Hcl	Paroxetine Hcl	38	11
Atenolol	Atenolol	37	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	31
Hydralazine Hcl	Hydralazine Hcl	36	12
Mounjaro	Tirzepatide	35	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Nystatin	Nystatin	33	23
Paxlovid	Nirmatrelvir/Ritonavir	33	31
Tolterodine Tartrate Er	Tolterodine Tartrate	33	suppressed
Valacyclovir	Valacyclovir Hcl	33	12
Naproxen	Naproxen	32	suppressed
Clonazepam	Clonazepam	29	suppressed
Fenofibrate	Fenofibrate	28	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Entresto	Sacubitril/Valsartan	26	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	25	suppressed
Divalproex Sodium	Divalproex Sodium	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Progesterone	Progesterone, Micronized	24	suppressed
Glipizide Er	Glipizide	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	18
Memantine Hcl	Memantine Hcl	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	11
Irbesartan	Irbesartan	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	11
Methocarbamol	Methocarbamol	19	suppressed
Mupirocin	Mupirocin	19	16
Prochlorperazine Maleate	Prochlorperazine Maleate	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	18
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Testosterone Cypionate	Testosterone Cypionate	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Cefdinir	Cefdinir	17	16
Lovastatin	Lovastatin	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Temazepam	Temazepam	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Cefuroxime	Cefuroxime Axetil	14	13
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	13	suppressed
Dexamethasone	Dexamethasone	13	suppressed
Lithium Carbonate	Lithium Carbonate	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Primidone	Primidone	13	suppressed
Armodafinil	Armodafinil	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Finasteride	Finasteride	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Baclofen	Baclofen	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error